CIDEA
Reaktivität: Human
ELISA
Wirt: Kaninchen
Polyclonal
HRP
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Buffer
In 1x PBS, pH 7.4
Handhabung
Aliquot to avoid repeated freezing and thawing.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Wang-Johanning, Rycaj, Plummer, Li, Yin, Frerich, Garza, Shen, Lin, Yan, Glynn, Dorsey, Hunt, Ambs, Johanning: "Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors." in: Journal of the National Cancer Institute, Vol. 104, Issue 3, pp. 189-210, (2012) (PubMed).
Ito, Nagasawa, Omae, Ide, Akasaka, Murakami: "Differential regulation of CIDEA and CIDEC expression by insulin via Akt1/2- and JNK2-dependent pathways in human adipocytes." in: Journal of lipid research, Vol. 52, Issue 8, pp. 1450-60, (2011) (PubMed).
Ito, Nagasawa, Hara, Ide, Murakami: "Differential roles of CIDEA and CIDEC in insulin-induced anti-apoptosis and lipid droplet formation in human adipocytes." in: Journal of lipid research, Vol. 51, Issue 7, pp. 1676-84, (2010) (PubMed).
Puri, Ranjit, Konda, Nicoloro, Straubhaar, Chawla, Chouinard, Lin, Burkart, Corvera, Perugini, Czech: "Cidea is associated with lipid droplets and insulin sensitivity in humans." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 22, pp. 7833-8, (2008) (PubMed).
Target
CIDEA
(Cell Death-Inducing DFFA-Like Effector A (CIDEA))